About BioSkepsis

Our Story

BioSkepsis is a product of EFEVRE TECH LTD, a biotechnology company founded in 2018 in Larnaca, Cyprus, specialising in laboratory automation and digitalisation for life-science laboratories. The name "EFEVRE" derives from the Greek word meaning "to invent," and that spirit of invention has guided everything we build.

After years of developing hardware robotics (AMGEL) and laboratory software (VITALE) for molecular and genetic workflows, we saw a recurring problem: researchers were drowning in literature. Over 40 million biomedical publications exist today, and the gap between finding papers and drawing defensible scientific conclusions was growing wider every year.

BioSkepsis was born from that gap. We set out to build not another search engine, but a scientific reasoning tool — one that helps researchers, regulatory experts, and investment professionals move from raw evidence to structured, traceable conclusions. The name "Skepsis" comes from the Greek word for critical examination, because we believe every scientific claim deserves scrutiny, not blind acceptance.

What We Do

BioSkepsis synthesises evidence from millions of peer-reviewed publications using an approach we call Evidence Funnelling — a layered process that narrows broad scientific questions into focused, citation-backed insights. Instead of returning generic summaries, BioSkepsis maps the biological "connective tissue" between genes, pathways, and phenotypes so you can see exactly why a conclusion holds or where it breaks down.

Whether you are a PhD student validating a hypothesis, a principal investigator writing a grant proposal, a regulatory expert assembling an HTA dossier, or a VC analyst performing scientific due diligence on a biotech startup — BioSkepsis gives you decision-grade evidence in minutes instead of weeks.

Get in Touch

Have questions or want to learn more? Reach us at info@bioskepsis.ai or visit efevre.com to learn about our full product line.